Navigation Links
Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
Date:12/15/2009

ntitative RT-PCR by Oncotype DX, to explore the association between polysomy 17 (extra copies of chromosome 17, a condition found in breast cancer patients that can complicate the interpretation of HER2 testing results), HER2 status and breast cancer death. Polysomy 17 was found in HER2-amplified tumors in approximately a third of cases. While differences were not statistically significant, HER2-positive patients with polysomy 17 tended to have a worse prognosis than other breast cancer patients. Quantitative RT-PCR by Oncotype DX for HER2 status is highly concordant with HER2 status assessed by FISH and therefore is an alternative to FISH.

About Oncotype DX®

The Oncotype DX breast cancer test is the only multigene expression test commercially available that has clinical evidence validating its ability to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. Additionally, the test report provides quantitative scores for certain individual genes. The Oncotype DX breast cancer test has been extensively evaluated in thirteen clinical studies involving more than 4,000 breast cancer patients worldwide, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology. As of November 2009, more than 8,000 physicians have ordered more than 120,000 tests in over 50 countries, and both Medicare and private health plans covering over 90 percent of U.S. insured lives, provide reimbursement for Oncotype DX for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive through contracts, agreements or policy decisions. Both the American Society of Clinical Oncology and the National Comprehensive Cancer Network recommend the use of Oncotype DX for patients with node-nega
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
2. New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
3. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
4. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
5. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
6. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
7. Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development
8. CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
9. Curemark CEO Presents at Epigenomics Conference
10. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
11. Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015   ICD-10 Charts ( www.icd10charts.com ) ... it has officially launched its newest line of ... and the new 4 Step ICD-10 Implementation Plan.  ... other ICD-10 Charts resources and mobile apps, are ... free-of-charge.  With the release of these resources, the ...
(Date:7/7/2015)... 2015 Berger & Montague, P.C., a ... firm with one of the largest and most ... Faruqi and Faruqi, LLP in settling three separate ... Pharmaceuticals LP, Cephalon, Inc., and Biogen, Inc., for ... Under the agreements, AstraZeneca will pay the largest ...
(Date:7/7/2015)... 7, 2015 Sequent Medical, a privately ... devices for the treatment of neurovascular disease, announced ... joined its Board of Directors.   ... device and healthcare industries experience.  He has successfully ... commercialized numerous leading-edge products.  His experience encompasses a ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
(Date:7/7/2015)... MA (PRWEB) , ... July 07, 2015 , ... The ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition ... and other men who have sex with men (MSM) and transgender women, the ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois ... board is limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) ... industry forward and are committed to making sure patients have access to cannabis ...
(Date:7/7/2015)... ... July 07, 2015 , ... Safe Catch is setting revolutionary purity limits for ... Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market and Wegmans are some of ... to test every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, ... the Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted to ... helping underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... promoting the establishment of telemedicine programs in communities throughout Georgia, announces the launch ... living in the rural communities of Hancock County, GA. The new program will ...
Breaking Medicine News(10 mins):Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... 2 (HealthDay News) -- Children born to women exposed to ... be more likely to experience wheezing early in life, according ... consumer products, including many hard plastic food containers, water bottles ... chemical is present in more than 90 percent of the ...
... Parents shouldn,t let up when it comes to discouraging ... of a study to be presented Monday, May 2, ... Denver. Previous research has shown that parents ... enforcing anti-smoking practices at home. Researchers, led by E. ...
... Alexandria, VA Though there have been significant improvements in the treatment ... data on the experience of end of life care for head ... the May 2011 issue of Otolaryngology-Head and Neck Surgery . ... of Veterans Affairs group has developed the Family Assessment of Treatment ...
... (HealthDay News) -- After reviewing more than 50,000 prescriptions for ... found that about 4 percent were given an overdose. ... the study found. "Almost one in 10 of the ... twice the dose that they should have received based on ...
... during early pregnancy may be associated with wheezing in children, ... Bisphenol A, or BPA is a chemical found in ... It is present in more than 90 percent of the ... BPA exposure causes asthma in mice, but no data exists ...
... (May 1, 2011) -- A drug commonly used to treat ... according to a study published in the May issue of ... kinase inhibitor, blocks the action of mammalian target of rapamycin ... tumor growth. It,s used to treat advanced renal cell carcinoma. ...
Cached Medicine News:Health News:Mom's Exposure to Plastics Chemical Tied to Baby's Wheeze 2Health News:Parents have role in smoking prevention 2Health News:FATE results prove to be useful in end-of-life care 2Health News:Young Kids' Prescriptions Not Always on the Mark 2Health News:BPA exposure may be associated with wheezing in children 2Health News:Renal cancer drug temsirolimus shows promise against mesothelioma 2
Hook Shaped Tip , Curved to the Left; with 30 cm long silicone tubing with connector; overall length 40mm; stainless steel...
Set of Five, Long, with side port; all approximately 75mm in length; in Stainless Steel....
8 mm diameter nylon handpiece; 100 mm handle with grooves for grip; Standard male luer taper fits most cannula hub and female luer taper....
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel....
Medicine Products: